Literature DB >> 24415860

Surgery for luminal Crohn's disease.

Takayuki Yamamoto1, Toshiaki Watanabe1.   

Abstract

Many patients with Crohn's disease (CD) require surgery. Indications for surgery include failure of medical treatment, bowel obstruction, fistula or abscess formation. The most common surgical procedure is resection. In jejunoileal CD, strictureplasty is an accepted surgical technique that relieves the obstructive symptoms, while preserving intestinal length and avoiding the development of short bowel syndrome. However, the role of strictureplasty in duodenal and colonic diseases remains controversial. In extensive colitis, after total colectomy with ileorectal anastomosis (IRA), the recurrence rates and functional outcomes are reasonable. For patients with extensive colitis and rectal involvement, total colectomy and end-ileostomy is safe and effective; however, a few patients can have subsequent IRA, and half of the patients will require proctectomy later. Proctocolectomy is associated with a high incidence of delayed perineal wound healing, but it carries a low recurrence rate. Patients undergoing proctocolectomy with ileal pouch-anal anastomosis had poor functional outcomes and high failure rates. Laparoscopic surgery has been introduced as a minimal invasive procedure. Patients who undergo laparoscopic surgery have a more rapid recovery of bowel function and a shorter hospital stay. The morbidity also is lower, and the rate of disease recurrence is similar compared with open procedures.

Entities:  

Keywords:  Crohn’s disease; Laparoscopic surgery; Resection; Strictureplasty; Surgery

Mesh:

Year:  2014        PMID: 24415860      PMCID: PMC3886035          DOI: 10.3748/wjg.v20.i1.78

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  78 in total

Review 1.  Comparison of conventional and nonconventional strictureplasties in Crohn's disease: a systematic review and meta-analysis.

Authors:  Lorna Campbell; Ronald Ambe; James Weaver; Sue M Marcus; Burt Cagir
Journal:  Dis Colon Rectum       Date:  2012-06       Impact factor: 4.585

Review 2.  A comprehensive review of strictureplasty techniques in Crohn's disease: types, indications, comparisons, and safety.

Authors:  Ronald Ambe; Lorna Campbell; Burt Cagir
Journal:  J Gastrointest Surg       Date:  2011-09-10       Impact factor: 3.452

3.  Symptomatic duodenal Crohn's disease: is strictureplasty the right choice?

Authors:  Francesco Tonelli; Giovanni Alemanno; Francesco Bellucci; Adriana Focardi; Alessandro Sturiale; Francesco Giudici
Journal:  J Crohns Colitis       Date:  2012-11-17       Impact factor: 9.071

4.  Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients.

Authors:  Victor Warren Fazio; Ravi P Kiran; Feza H Remzi; John Calvin Coffey; Helen Mary Heneghan; Hasan Tarik Kirat; Elena Manilich; Bo Shen; Sean T Martin
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

5.  Scheduled infliximab monotherapy to prevent recurrence of Crohn's disease following ileocolic or ileal resection: a 3-year prospective randomized open trial.

Authors:  Koji Yoshida; Ken Fukunaga; Hiroki Ikeuchi; Koji Kamikozuru; Nobuyuki Hida; Yoshio Ohda; Yoko Yokoyama; Masaki Iimuro; Naohisa Takeda; Kyoichi Kato; Risa Kikuyama; Kazuko Nagase; Kazutoshi Hori; Shiro Nakamura; Hiroto Miwa; Takayuki Matsumoto
Journal:  Inflamm Bowel Dis       Date:  2011-11-13       Impact factor: 5.325

Review 6.  Complications of peristomal recurrence of Crohn's disease: a case report and a review of literature.

Authors:  Frank Hoentjen; Janice C Colwell; Stephen B Hanauer
Journal:  J Wound Ostomy Continence Nurs       Date:  2012 May-Jun       Impact factor: 1.741

Review 7.  Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis.

Authors:  Uri Kopylov; Shomron Ben-Horin; Oded Zmora; Rami Eliakim; Lior H Katz
Journal:  Inflamm Bowel Dis       Date:  2012-03-29       Impact factor: 5.325

8.  Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease.

Authors:  Quy Le; Gil Melmed; Marla Dubinsky; Dermot McGovern; Eric A Vasiliauskas; Zuri Murrell; Andrew Ippoliti; David Shih; Manreet Kaur; Stephan Targan; Phillip Fleshner
Journal:  Inflamm Bowel Dis       Date:  2013-01       Impact factor: 5.325

9.  A new antimesenteric functional end-to-end handsewn anastomosis: surgical prevention of anastomotic recurrence in Crohn's disease.

Authors:  Toru Kono; Toshifumi Ashida; Yoshiaki Ebisawa; Naoyuki Chisato; Kotaro Okamoto; Hidetoshi Katsuno; Kotaro Maeda; Mikihiro Fujiya; Yutaka Kohgo; Hiroyuki Furukawa
Journal:  Dis Colon Rectum       Date:  2011-05       Impact factor: 4.585

Review 10.  The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.

Authors:  Greg Rosenfeld; Hong Qian; Brian Bressler
Journal:  J Crohns Colitis       Date:  2013-03-05       Impact factor: 9.071

View more
  17 in total

1.  Kono-S Anastomosis for Surgical Prophylaxis of Anastomotic Recurrence in Crohn's Disease: an International Multicenter Study.

Authors:  Toru Kono; Alessandro Fichera; Koutarou Maeda; Yoshiharu Sakai; Hiroki Ohge; Mukta Krane; Hidetoshi Katsuno; Mikihiro Fujiya
Journal:  J Gastrointest Surg       Date:  2015-12-22       Impact factor: 3.452

Review 2.  Assessment of stricturing Crohn's disease: Current clinical practice and future avenues.

Authors:  Dominik Bettenworth; Tobias M Nowacki; Friederike Cordes; Boris Buerke; Frank Lenze
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 3.  Surgical recurrence in Crohn's disease: Are we getting better?

Authors:  Ivan Kristo; Anton Stift; Michael Bergmann; Stefan Riss
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

4.  Robotic ileocolic resection with intracorporeal anastomosis for Crohn's disease.

Authors:  H Hande Aydinli; Marissa Anderson; Amanda Hambrecht; Mitchell A Bernstein; Alexis L Grucela
Journal:  J Robot Surg       Date:  2020-07-28

5.  Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study.

Authors:  Takayuki Yamamoto; Antonino Spinelli; Yasuo Suzuki; Rogerio Saad-Hossne; Fabio Vieira Teixeira; Idblan Carvalho de Albuquerque; Rodolff Nunes da Silva; Ivan Folchini de Barcelos; Ken Takeuchi; Akihiro Yamada; Takahiro Shimoyama; Lorete Maria da Silva Kotze; Matteo Sacchi; Silvio Danese; Paulo Gustavo Kotze
Journal:  United European Gastroenterol J       Date:  2015-08-06       Impact factor: 4.623

6.  Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's Colitis.

Authors:  Sasha Taleban; Martijn G H Van Oijen; Eric A Vasiliauskas; Phillip R Fleshner; Bo Shen; Andrew F Ippoliti; Stephan R Targan; Gil Y Melmed
Journal:  Dig Dis Sci       Date:  2015-10-05       Impact factor: 3.199

Review 7.  Minimally invasive surgery for inflammatory bowel disease: Review of current developments and future perspectives.

Authors:  Philipp-Alexander Neumann; Emile Rijcken
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

8.  Risk factors for initial surgery in patients with Crohn's disease in Central China.

Authors:  Min Chen; Fengming Yi; Feng Zhou; Meifang Huang; Jin Li; Wenfeng Yan; Lixia Li; Bing Xia
Journal:  Surg Today       Date:  2014-12-20       Impact factor: 2.549

9.  Factors Associated with Short-Term Morbidity in Patients Undergoing Colon Resection for Crohn's Disease.

Authors:  H Hande Aydinli; Erman Aytac; Feza H Remzi; Mitchell Bernstein; Alexis L Grucela
Journal:  J Gastrointest Surg       Date:  2018-04-16       Impact factor: 3.452

10.  Elective surgery outcomes in inflammatory bowel disease: interpretation at magnetic resonance enterography.

Authors:  Giuseppe Cicero; Giorgio Ascenti; Alfredo Blandino; Renato Trimarchi; Christian Booz; Thomas J Vogl; Tommaso D'Angelo; Silvio Mazziotti
Journal:  Jpn J Radiol       Date:  2021-02-24       Impact factor: 2.374

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.